Tag Archives: bladder cancer

Novel, targeted canine cancer therapy receives US patent

Photo: Maria Sbytova/Adobe Stock

FidoCure, the flagship brand of the One Health Company, has been granted a patent for a novel targeted therapy and biomarker for canine cancer by the US Patent and Trademark Office (USPTO). The patent covers a new approach to treatment, using mutation profiling to better manage bladder cancer in dogs.1

The now-patented approach, driven by artificial intelligence (AI), considers real-world evidence from veterinary clinical data and uses it to determine the ideal methodology for therapeutic treatment. Early data reports suggest the new approach may be more efficacious compared to conventional treatment methods.1

“This patent acknowledges the uniqueness of our approach, which has consistently demonstrated that it can transform outcomes for pet dogs with cancer while improving the quality of life for the patients,” Christina Lopes, cofounder and CEO of the One Health Company and FidoCure, said in a news release.1 “Receiving a patent is an important milestone in our mission to increase access to lifesaving treatments for pet dogs with cancer.”

Each year, 6 million dogs in the US are affected by cancer, and many of them by bladder cancer.1 Transitional cell carcinoma (TCC) is the tumor that affects the bladder, and Atlantic Veterinary Internal Medicine and Oncology (AVIMO) approximates that TCC is diagnosed in 80,000 dogs each year.2 Biologically speaking, canine cancer is relatively similar to human cancer, but, according to FidoCure, treatment and care for canine cancer is about 20 years behind humans.1

“Bladder cancer [treatment] in dogs is an unmet need,” Gerald Post, DVM, MEM, CACVIM, chief medical officer of One Health, said in a news release.1 “Traditional chemotherapy and radiation therapy are often ineffective, cause toxic side effects, and are expensive.”

The patent, No. 12036281-B2, protects FidoCure’s technology for 20 years following its priority date.1 Lopes, alongside her FidoCure cofounder Benjamin Lewis and other key team members, are named as inventors on the patent. The company currently has an additional 8 pending patents, covering novel therapeutics and biomarkers, and will be seeking approval from the FDA for their products in the near future, according to the release.1

FidoCure came together with the goal to improve outcomes for canine cancer patients. More specifically, the founders wanted to put an end to blanket chemotherapy and radiation treatments, regardless of cancer type, citing the use of target therapies in human oncology. They’ve since partnered with a board of medical and veterinary advisors with multidisciplinary knowledge, spanning the fields of human and canine oncology.3

Among the company’s achievements is the FidoCure Next Generation Sequencing Test, through which the results allow care providers to better customize treatment options using targeted therapies. In early 2022, FidoCure partnered with IDEXX, a company focused on global pet healthcare innovation, to provide access to the test to its’ veterinary clients throughout the US and Canada.4

References

  1. FidoCure Receives Patent for AI-Driven Drug Development, Accelerating a Novel Portfolio of Precision Therapeutic for Cancer. News release. FidoCure. August 13, 2024. Accessed August 15, 2024. https://www.businesswire.com/news/home/20240813574729/en/FidoCure-Receives-Patent-for-AI-Driven-Drug-Development-Accelerating-a-Novel-Portfolio-of-Precision-Therapeutic-for-Cancer
  2. Understanding Bladder Cancer in Dogs. American Veterinary Internal Medicine and Oncology. Accessed August 15, 2024. https://avim.us/bladder-cancer-in-dogs/
  3. FidoCure. AI Driven Precision Medicine Platform for Canine Cancer. One Health Company. Accessed August 15, 2024. https://fidocure.com/
  4. One Health Company partners with IDEXX to enhance canine cancer care. dvm360. January 20, 2022. Accessed August 23, 2024. https://www.dvm360.com/view/one-health-company-partners-with-idexx-to-enhance-canine-cancer-care

Source: MJH Life Sciences, DVM 360

Dogs absorb lawn chemicals

Dogs exposed to garden and lawn chemicals may have a higher risk of bladder cancer. iStockPhoto

Dogs exposed to garden and lawn chemicals may have a higher risk of bladder cancer.
iStockPhoto

 

Dogs are ingesting, inhaling and otherwise being exposed to garden and lawn chemicals that have been associated with bladder cancer, according to a new study.

The paper, which will appear in the July issue of Science of the Total Environment, also found that wind could carry the chemicals to untreated properties. The researchers also found that dogs, once contaminated by the chemicals, can transfer them to their owners.

The chemicals are common herbicides containing the following: 2,4-dichlorophenoxyacetic acid (2,4-D), 4-chloro-2- methylphenoxypropionic acid (MCPP) and/or dicamba.

“The routes of exposure that have been documented in experimental settings include ingestion, inhalation and transdermal exposures,” lead author Deborah Knapp of Purdue University’s Department of Veterinary Clinical Sciences, told Discovery News.

“In the case of dogs,” she added, “they could directly ingest the chemicals from the plant, or they could lick their paws or fur and ingest chemicals that have been picked up on their feet, legs or body.”

Scottish terriers, West Highland white terriers, Shetland sheepdogs, beagles and wire hair fox terriers are all at particular risk, the researchers suggest, because these breeds have a high genetic propensity for bladder cancer.

Knapp and her colleagues first conducted an experimental grass plot study that involved spraying various defined patches with the chemicals under different conditions. These included spraying the herbicides on plots that were green, dry brown, wet or recently mowed. The researchers next measured how much of the chemicals remained on the grass up to 72 hours post treatment.

Co-author Angus Murphy, also from Purdue, explained that dead or dying plant material does not readily absorb the chemicals, “so the herbicide can remain longer on the surface of the plant.”

He continued, “If an excessive amount of herbicide is applied, then the capacity of the target plant to take up the compound may be overwhelmed.”

In a second experiment, the researchers analyzed urine samples of dogs from households that either used herbicides or didn’t. The majority of dogs from homes that used the chemicals were found to have these same herbicides in their urine. Some dogs from untreated homes also had the chemicals in their urine.

Knapp explained that wind could cause the herbicides to travel up to 50 feet away from the application site. Neighbors who use the chemicals might therefore impact other individuals in the area.

“There are industry guidelines for restricting lawn chemical application based on wind speed, although homeowners may not be aware of these,” Knapp said.

Once contaminated, dogs can pass the chemicals on to their owners and to others. The study only looked at dogs, but the researchers suspect that cats and other pets could also be affected.

“Dogs can pick up the chemicals on their paws and their fur,” Knapp said. “They can then track the chemicals inside the house, leaving chemicals on the floor or furniture. In addition, if the dog has chemicals on its fur, the pet owner could come in contact with the chemicals when they pet or hold the dog.”

John Reif, a professor emeritus of epidemiology at the Colorado School of Public Health, told Discovery News, “The paper presents important information since exposure to 2,-4-D, a widely used broad leaf herbicide, has been associated with increased risk of cancer in pet dogs and humans.”

Reif added, “This study has potentially important implications for human health since it demonstrates widespread exposure to pet dogs. The likelihood that children, who share the local environment with their pets, are similarly exposed to these chemicals is high and thus additional studies should be conducted to evaluate this possibility.”

The researchers suggest that if owners still must use herbicides, they should follow manufacturer guidelines, allow gardens and lawns to dry before allowing pets out, wash their dog’s feet each time the dog comes inside, and consider treating the back yard one week before the front (or vice versa) so that pets will have an area of less potential chemical exposure available to them.

Source:  Discovery.com

 

Diagnosis and treatment of bladder cancer in dogs

Veterinary researchers at Oregon State University have identified a unique group of proteins that indicate the presence of transitional cell carcinoma – the most common cause of bladder cancer – and may lead to a new assay which could better diagnose this disease in both dogs and humans.

Photo by Shay Bracha, Oregon State University

Photo by Shay Bracha, Oregon State University

Sheepdogs, collies, and terriers seem particularly susceptible to this type of cancer.  By the time the cancer is diagnosed, it is usually too late to save the dog’s life.

An improved assay to detect this serious disease much earlier in both animals and humans should be possible, scientists said, and may even become affordable enough that it could be used as an over-the-counter product to test urine, much like a human pregnancy test. Some of the work may also contribute to new therapies, they said.

“Research of this type should first help us develop a reliable assay for this cancer in dogs, and improve the chance the disease can be caught early enough that treatments are effective,” said Shay Bracha, an assistant professor in the OSU College of Veterinary Medicine.

Source:  Oregon State University media statement